Salemonline Journal

Crohn’s Disease Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies Working in the market

 Breaking News
  • No posts were found

Crohn’s Disease Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies Working in the market

February 24
18:32 2023
Crohn's Disease Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies Working in the market
Delveinsight Business Research LLP
DelveInsight’s “Crohn’s Disease Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of Crohn’s Disease, historical and forecasted epidemiology as well as the Crohn’s Disease market trends in the United States, EU4 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

DelveInsight’s “Crohn’s Disease Market Insights, Epidemiology, and Market Forecast-2032 report delivers an in-depth understanding of Crohn’s Disease, historical and forecasted epidemiology as well as the Crohn’s Disease market trends in the United States, EU4 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

Some of the Key Facts of the Crohn’s Disease Market Report:

  • Crohn’s disease is most common in western Europe and North America, where it has a prevalence of 100 to 300 per 100,000 people. More than half a million Americans are currently affected by this disorder.

 Key Benefits of the Crohn’s Disease Market report:

  • The report covers a descriptive overview of Crohn’s Disease, explaining its causes, symptoms, pathophysiology, genetic basis, diagnosis, and currently available therapies.

  • Comprehensive insight has been provided into Crohn’s Disease epidemiology and treatment.

  • Additionally, an all-inclusive account of both the current and emerging therapies for Crohn’s Disease is provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape.

  • A detailed review of the Crohn’s Disease market; historical and forecasted is included in the report, covering the 7MM drug outreach.

  • The report provides an edge while developing business strategies, by understanding trends shaping and driving the 7MM Crohn’s Disease market.

Got queries? Click here to know more about the Crohn’s Disease Market Landscape

Crohn’s Disease Overview

Crohn’s Disease is a type of Inflammatory Bowel Disease (IBD). It causes inflammation of the digestive tract, leading to abdominal pain, severe diarrhea, fatigue, weight loss, and malnutrition. Inflammation caused involve different areas of the digestive tract in different people. However, this type of IBD most commonly affects the small intestine and the start of the colon. This can cause patches of inflammation that damage multiple layers of the GI tract wall. can be painful and sometimes may lead to life-threatening complications.

Crohn’s is sometimes described as a chronic condition. This means that it is ongoing and life-long. The disease runs a benign course with few flare-ups in many people, while other people may have more severe diseases. The CD is not infectious.

Crohn’s Disease Epidemiological Insights

  • Total prevalent population of Crohn’s Disease in 7MM was estimated to be 1,613,413 cases in 2021, which is expected to increase by 2032.

  • The US accounted for the highest prevalent population of Crohn’s Disease among 7MM with 832,145 cases in 2021.

  • The estimates suggest a higher diagnosed prevalence of Crohn’s Disease in the United States with 595,304 diagnosed cases in 2021.

  • Among the European countries, the total prevalent population of Crohn’s Disease was highest in Germany with 227,320 cases followed by the UK with 147,819 cases in 2021. Spain reported the least number of cases among EU-5 with 74,665 cases in 2021.

  • Epidemiology assessed for Crohn’s Disease showed that Japan accounts for approximately 147,382 prevalent cases of CD in 2021.

  • The estimates suggest in the United States, the age-specific diagnosed cases of Crohn’s disease (CD) were 353,611; 167,876; 67,865, and 5,953 cases for the age groups 18–44 years, 45–64 years, 65–84 years, and ≥85 years in 2021.

  • As per DelveInsight’s analysis, the total cases of mild CD and moderate to severe CD were found to be 42,174 and 63,261 respectively in Japan in 2021.

 Crohn’s Disease Epidemiological Segmentation 

  • Crohn’s Disease total prevalent cases

  • Crohn’s Disease severity-specific prevalence 

  • Crohn’s Disease gender-specific prevalence

Crohn’s Disease Market Outlook 

Crohn’s disease  is an inflammatory bowel disease (IBD) which are a group of disorders that cause chronic inflammation (pain and swelling) in the intestines. Crohn’s Disease is progressive in nature with long-term damage to intestinal mucosal structures and recurrent attacks with acute exacerbations if not controlled and appropriately treated.

 Crohn’s Disease is often characterized by the formation of strictures, fistulas, ulcers, and granulomas in the mucosal layers of the intestine. It causes inflammation of the digestive tract lining, leading to abdominal pain, severe diarrhea, fatigue, weight loss, and malnutrition. However, the gastrointestinal manifestation associated with Crohn’s Disease can primarily affect the terminal ileum and colon. Additionally, it can compromise any region from the mouth to the rectum of the affected patients.

 Treatment effects and risk factors differ in different populations. The goal of medical treatment is to stop the abnormal inflammation so intestinal tissue has a chance to heal. As it does, the symptoms of diarrhea and abdominal pain should be relieved. Once the symptoms are under control, medical treatment will focus on decreasing the frequency of flare-ups and maintaining remission.

 Learn more by requesting for sample @ Crohn’s Disease Market Landscape

Crohn’s Disease Key Companies

  • Takeda Pharmaceutical

  • Janssen Pharmaceuticals

  • UCB

  • And many more 

 Crohn’s Disease Therapies 

  • Entyvio (Vedolozumab)

  • Jyselica (Filgotinib

  • Mirikizumab (LY3074828)

  • And many more 

 Crohn’s Disease Market Drivers 

  • Growing cases of vision loss

  • Technological advancements in the type or range of treatments available on the market such as LASIK surgery

  • And many others.

 

Crohn’s Disease Market Market Barriers 

  • Treatment costs

  • Need for novel therapeutics

  • Entry of biosimilars

  • And many others.

 Table of Contents

  •  Key Insights 

  •  Report Introduction 

  •  Executive Summary of Crohn’s Disease  

  •  Disease Background and Overview

  •  Epidemiology and patient population

  •  Crohn’s Disease Emerging Therapies

  • Crohn’s Disease  Market Outlook

  •  Market Access and Reimbursement of Therapies

  • Appendix

  • Crohn’s Disease  Report Methodology

  • DelveInsight Capabilities

  •  Disclaimer

  •  About DelveInsight

Click here to read more about Crohn’s Disease market

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/